UnitBar
The UAB CFAR offers many different services and programs to assist in the development of investigators who are conducting HIV/AIDS research. Such resources include:

  Core Services and Specialized Equipment through 7 core facilities                                                                                                                        

  Developmental Funding Programs for early career investigators or mid-career faculty who are interested in new research areas
    (join our mailing list to receive notices)
    • CFAR Developmental Pilot Awards Program
    • Creative and Novel Ideas in HIV Research (CNIHR) Funding Program
    • Assistance with NIH Administrative Supplements for CFAR and CNICS-based studies
    • Pilot project and travel awards to develop international studies at K-RITH in Durban, South Africa through our Infectious Diseases, Global Health and Vaccines Research Initiative.  Check the website for new RFAs.
    • Access to the HIV and Aging R24 Pilot Awards Program managed by the Pepper Center at Wake Forest University and UAB's CFAR Administrative Core. Signup for our listserv for notices of RFAs.

  Linkages to experts and leaders in the field for Mentoring and unique expertise for Consultation Services                                                                         

  Fostering Collaborative Interactions through sponsorship of working groups, invited speakers and managing National Research Networks                  
    • Interdisciplinary Research Groups (IRGs), more info
    • A-CTU, CNICS network, CNIHR funding program, WIHS cohort and the 1917 Cohort, more info
    • CFAR Monthly Seminar Series (join our mailing list to receive notices)
    • 1917 Clinical Cohort Meeting (meets most Fridays, This email address is being protected from spambots. You need JavaScript enabled to view it. to receive notices)

  Connecting investigators, staff and trainees to funding notices, conferences, and educational opportunities of interest to those working in HIV/AIDS                                                                                                                                                                                                                                
    • Monthly digests and notices through our Mailing List
    • Website
    • Facebook
    • Twitter

  Use of the CFAR Conference Room and Equipment for meetings                                                                                                                             

  Access to the CFAR Sharepoint Site for secure document sharing                                                                                                                            


CFAR Conference Room


IMAG0535The CFAR offers the use of its conference room and amenities to the UAB community. Located in the CFAR offices in suite 256 of the Bevill Biomedical Research Building (BBRB 256), the conference room comfortably seats 15-25 people. The room is equipped with a PC-computer, Smartboard, mounted projector, and wireless polycom conference phone. 
Reserve CFAR Conference RoomCFAR Conference Room Calendar

National CFAR


The Centers for AIDS Research (CFAR) program at the National Institutes of Health provides administrative and shared research support to synergistically enhance and coordinate high quality AIDS research projects. CFARs accomplish this through core facilities that provide expertise, resources, and services not otherwise readily obtained through more traditional funding mechanisms.

The CFAR program emphasizes the importance of interdisciplinary collaboration, especially between basic and clinical investigators as well as behavioral scientists to support translational research. The CFAR program also encourages training and mentoring of young investigators as well as an inclusion of women and minorities.

National CFAR Site

Funding Opportunities



Most recent funding notices are shared via our CFAR Newsletter and Listserv postings.  Sign up to receive these notices here.

STANDARD HIV/AIDS RELATED FUNDING NOTICES:

Link to all NIAID Funding Opportunities and Notices Here

Link to HIV-related Funding Opportunities at NHLBI Here


UAB's CCTS External Funding Opportunities Listing

http://www.uab.edu/ccts/ResearchCommons/Pages/Funding.aspx?utm_source=CCTS+Digest+6%2F27%2F14&utm_campaign=06%2F27%2F14+Digest&utm_medium=email


Targeting Latently Infected Cells Without Reactivation (R01)
R01 Research Project Grant
The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative research that advances the understanding of mechanisms or approaches that could be harnessed to selectively eliminate HIV-1 latently-infected cells without depending on viral reactivation. The ultimate goal is to inform the design of future therapeutic approaches that could be used to eradicate the latent reservoir that persists in the context of optimally suppressive highly active antiretroviral therapy (HAART), thereby affecting a permanent cure for HIV infection. Cross-disciplinary collaborations enabling technology-driven strategies are strongly encouraged.

Prevention Innovation Program (PIP) (R01)
RFA-AI-13-059

This Funding Opportunity Announcement (FOA), the Prevention Innovation Program (PIP), encourages Research Project Grant (R01) applications in non-vaccine biomedical prevention (nBP) research. The PIP is intended to support high-risk/innovative research and development efforts to establish and maintain a sustainable pipeline for the prevention of HIV acquisition/transmission. The PIP will support discovery and development of novel and under-explored nBP candidates/strategies, nBP delivery strategies, studies of the impact of nBP prevention strategies on genital and gastrointestinal (GI) mucosa function and emerging technologies that support microbicides, pre-exposure prophylaxis (PrEP), and Multipurpose Prevention Technologies (MPT) for prevention of HIV acquisition/transmission.

LOI Due: June 10, 2014
Application Receipt Date: July 10, 2014


UNITAID Call for LOIs for Innovative Ideas to Increase Access to Treatment, Diagnostic, and Preventive Products for HIV/AIDS, TB, and Malaria

UNITAID will be accepting letters of intent (LOIs) on proposed projects until 15 May. LOIs are short conceptual presentations of proposed projects that can be submitted online in either English or French. Proponents with successful LOIs are invited to submit full project proposals for UNITAID funding. Call details and LOI submission guidelines are available at: http://www.unitaid.org/calls.

LOI Receipt: May 15, 2014

Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R21) (R01)
RFA-AI-13-059

This Funding Opportunity Announcement (FOA) encourages applications that propose to understand and address social determinants associated with the prevention and treatment of HIV. This FOA describes two research endeavors that are unique and overlapping.  The first is to characterize those social determinants that are most relevant to HIV prevention and treatment outcomes, particularly in their association with inequities in HIV risk or disease outcomes. The second is to develop and test structural interventions aimed at reducing the negative impact or maximizing positive aspects of social determinants. 

Application Receipt Date: May 7, 2014

   RFA-AI-14-019, Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01)

   NIAID-DAIDS-NIHAI2013177, Synthesis of Therapeutic Agents for Treatment of Infectious Diseases

   PA-14-150, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (Parent F30)

   PA-14-147, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

   PA-14-148, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31, Diversity)

   PA-14-149, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

   RFP-NIAID-DAIDS-NIHAI2014002, Clinical Pharmacology Quality Assurance Program


Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care
Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research
Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care
Accelerating Improvements in the HIV Care Continuum
Strengthening Adherence to Antiretroviral-Based HIV Treatment and Prevention

RFA-AI-14-006--Innovation for HIV Vaccine Discovery (R01)                                    
National Institute of Allergy and Infectious Diseases/NIH/DHHS  
RFA-AI-14-006   14-Jun-2014
Eradication of HIV-1 from Central Nervous System Reservoirs (R01)                        
National Institute of Mental Health/NIH/DHHS    
PA-14-095          06-May-2014

RFA-AI-14-018--U.S.-South Africa Program for Collaborative Biomedical Research (U01)          
National Institute of Allergy and Infectious Diseases/NIH/DHHS    RFA-AI-14-018                                                                            
21-Mar-2014

RFA-DA-15-004--NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)       
National Institute on Drug Abuse/NIH/DHHS         
RFA-DA-15-004  28-Jul-2014

RFA-HL-14-024--Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01)           
National Heart, Lung, and Blood Institute/NIH/DHHS                                                
RFA-HL-14-024                        07-Apr-2014

RFA-HL-14-029--Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R21)           
National Heart, Lung, and Blood Institute/NIH/DHHS                                                
RFA-HL-14-029                        07-Apr-2014

RFA-DA-15-005--Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)    
National Institute on Drug Abuse/NIH/DHHS       
RFA-DA-15-005  29-Jun-2014

RFA-AA-14-004--Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01)     
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS                                            
RFA-AA-14-004                       
20-Mar-2014

RFA-HL-14-023--Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01)                                                                            
National Heart, Lung, and Blood Institute/NIH/DHHS     
RFA-HL-14-023  07-Apr-2014

RFA-AI-13-059--Prevention Innovation Program (PIP) (R01)                                       
National Institute of Allergy and Infectious Diseases/NIH/DHHS  
RFA-AI-13-059   09-Jun-2014



International Research in Infectious Diseases, including AIDS (R01)
PAR-14-080
http://grants.nih.gov/grants/guide/pa-files/PAR-14-080.html
The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of R01 applications from institutions in eligible foreign countries to conduct studies in infectious disease research. Collaborations with investigators in the United States (U.S.) are encouraged but not required. These grants will serve to build independent research capacity by providing direct funding to investigators who do not currently have NIH-funded grant or contract awards for research projects. The intent of these activities is to advance the development of local scientific expertise. Clinical trials will not be supported.
 
Applications may request a budget of up to $125,000 per year in direct costs and a maximum of $625,000 direct costs over a five-year project period. PDs/PIs must have a primary appointment at an institution/organization in an eligible country. Foreign investigators who currently serve as Principal Investigators on grants (other than an expiring IRIDA) or contracts funded by NIH are not eligible to apply. 
 
AIDS application receipt date (S): August 22, 2014; August 21, 2015; August 19, 2016,

Beyond HAART:  Innovative Approaches to Cure HIV-1 (U19)
NIAID and NHLBI recently announced a major research funding opportunity designed to spur the development of novel approaches to eliminate HIV. Both institutes expect to fund three to six grants for a total of roughly $11.2 million per year for five years through the new request for applications (RFA). Application deadline is July 28, 2014.

OAIC/CFAR HIV/Aging Pilot Awards Initiative
The purpose of this funding mechanism is to promote aging research among the CFAR investigators and engage OAIC researchers in the field of HIV. Four one-year pilot awards will be made of up to $30,000 each. Download the full RFA for instructions and forms. Deadline for concept proposals is February 3rd, 2014. 

CLOSED for 2014, New RFA likely in 2015 

Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01)
(RFA-HL-14-023)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015

Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01)
(RFA-HL-14-024)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015

Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R21)
(RFA-HL-14-029)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015

Beyond HAART: Innovative Approaches to Cure HIV-1 (U19)
(NOT-AI-14-005)

SEE the NHLBI Website For Details
  

Sponsor: National Institute of Mental Health/NIH/DHHS
Program Number: 23777
Title: Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R21)                                                                                                                                                         
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-11-277.html
SYNOPSIS:  The sponsor invites applications for innovative
intervention development research to advance HIV prevention and care.
This FOA encourages research designed to (a) conduct tests of the
efficacy of novel behavioral and/or integrated behavioral and
biomedical interventions, (b) conduct basic behavioral and social
science research that is needed to advance the development of
innovative interventions, and (c) translate and operationalize the
findings from these basic studies to develop interventions and assess
their feasibility. This program will use the NIH
Exploratory/Developmental (R21) grant mechanism.  <S2S>
Deadline(s): 10/16/2013
                  01/07/2014
                  02/16/2014
                  05/07/2014


Sponsor: National Institute on Drug Abuse/NIH/DHHS
Program Number: 04292
Title: HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01)                                                                                                                                                                                               
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Program URL: http://grants1.nih.gov/grants/guide/pa-files/PA-12-281.html
SYNOPSIS:   National Institute on Drug Abuse (NIDA) invites
applications for  research to identify the role(s) that drug abuse
plays in fueling the epidemic in vulnerable groups (racial/ethnic
minorities, men who have sex with men (MSM), youth) in the United
States and to develop effective interventions to prevent new
infections and to improve the health and well-being of those living
with HIV/AIDS. This FOA will support studies in vulnerable populations
to: 1) understand the contribution of drug abuse (both injection and
non-injection) to the acquisition and/or transmission of HIV; 2) study
disease progression and disease outcomes; 3) develop and/or improve
prevention and treatment interventions, particularly comprehensive,
integrated interventions; 4) improve the availability, delivery and
quality of evidence-based prevention and treatment services across a
variety of settings; and 5) address organizational, structural, and/or
community level factors including social, drug-using, and sexual
networks associated with health disparities.  This program will use
the (R01) grant mechanism.    <S2S>
Deadline(s): 01/07/2014
                  05/07/2014
                  09/07/2014
                  01/07/2015
                  05/07/2015
                  09/07/2015
                  01/07/2016

The NIH is excited to release its first round of funding opportunities in support of the President’s BRAIN Initiative. Collectively, these opportunities focus on building a new arsenal of tools and technologies for helping scientists unlock the mysteries of the brain.

RFA-MH-14-215 BRAIN Initiative:  Transformative Approaches for Cell-Type Classification in the Brain (U01)  http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-14-215.html , Application due date:  March 13, 2014, by 5:00 PM local time of applicant organization.

RFA-MH-14-216 BRAIN Initiative:  Development and Validation of Novel Tools to Analyze Cell-Specific and Circuit-Specific Processes in the Brain (U01)  http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-14-216.html,  Application due date:  March 13, 2014, by 5:00 PM local time of applicant organization.

RFA-NS-14-007 BRAIN Initiative:  New Technologies and Novel approaches for Large-Scale Recording and Modulation in the Nervous System (U01)  http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-14-007.html , Application due date:   March 24, 2014, by 5:00 PM local time of applicant organization.

RFA-NS-14-008 BRAIN Initiative:  Optimization of Transformative Technologies for Large-Scale Recording and Modulation in the Nervous System (U01)  http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-14-008.html , Application due date:    March 24, 2014, by 5:00 PM local time of applicant organization.

RFA-NS-14-009 BRAIN Initiative:  Integrated Approaches to Understanding Circuit Function in the Nervous System (U01)  http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-14-009.html , Application due date:    March 24, 2014, by 5:00 PM local time of applicant organization..

RFA-MH-14-217 BRAIN Initiative:  Planning for Next Generation Human Brain Imaging (R24)  http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-14-217.html  Application due date:  March 13, 2014, by 5:00 PM local time of applicant organization.

The receipt dates for these FOAs are in March.  If you have specific questions about any of the FOAs, please contact the Scientific/Research Contact(s) listed in the announcement.  These announcements are the first step in the BRAIN Initiative at NIH.  Further information about the BRAIN Initiative can be found at http://www.nih.gov/science/brain/index.htm.


Sponsor:      National Institute on Aging/NIH/DHHS

Title:        Development and Characterization of Animal Models for Aging Research(R01)

Contact:      Mahadev Murthy, Ph.D., M.B.A.

Tel:          301-402-7749

Email:        This email address is being protected from spambots. You need JavaScript enabled to view it.

Full Program: http://grants1.nih.gov/grants/guide/pa-files/PA-13-155.html

DeadlineNote:The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7annually. This program will expire on September 8, 2016.  National Institute on Aging (NIA) and National Institute on Deafness and Other Communication Disorders (NIDCD) invite applications for research that develops, characterizes, refines, and enhances model systems for research on aging.  This FOA will use the NIH Research Project (R01) award mechanism.


Sponsor:      National Institute of Dental and Craniofacial Research/NIH/DHHS

Title:        Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R01)

Contact:      Isaac R. Rodriguez-Chavez, Ph.D., M.S., M.H.S.

Tel:          301-594-7985

Email:        This email address is being protected from spambots. You need JavaScript enabled to view it.

Full Program: http://grants1.nih.gov/grants/guide/pa-files/PA-11-334.html

The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014.  The sponsor invites applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies againstHIV, oral co-infections and oral opportunistic infections.  This FOA will use the NIH Research Project (R01) award mechanism.


Sponsor:      National Institute of Dental and Craniofacial Research/NIH/DHHS

Title:        Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R21)

Contact:      Isaac R. Rodriguez-Chavez, Ph.D., M.S., M.H.S.

Tel:          301-594-7985

Email:        This email address is being protected from spambots. You need JavaScript enabled to view it.

Full Program: http://grants1.nih.gov/grants/guide/pa-files/PA-11-333.html

The deadlines for receipt ofAIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014.

The sponsor invites applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies againstHIV, oral co-infections and oral opportunistic infections.  This program will use the NIH Exploratory/Developmental (R21) grant mechanism.  <S2S>


Sponsor:      National Cancer Institute/NIH/DHHS

Title:        Revision Applications to R01 Awards for Research on Detection of Pathogen-Induced Cancer (DPIC) (R01)

Contact:      Jacob Kagan, M.Sc., Ph.D.

Tel:          (301) 435-1594

Email:        This email address is being protected from spambots. You need JavaScript enabled to view it.

Full Program: http://grants1.nih.gov/grants/guide/pa-files/PAR-13-172.html

Optional letters of intent will be accepted thirty days prior to the application deadline. The deadlines for receipt of full applications are: July 10, 2013; December 11,2013; July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization.  This FAO will expire on December 12, 2015. NationalCancer Institute (NCI) invites revision applications (formerly called "competing revisions") from investigators with active NIH R01 research grants. These revision applications are expected to focus on the interactions of carcinogenic pathogens with the human microbiome and the host for the detection of pathogen-induced cancer (DPIC). This FOA encourages research to assess molecular signatures associated with risk and early detection of pathogen-induced cancer and chronic inflammation associated with progression to invasive cancer. Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent R01 award.  This FOA will utilize the NIH R01 Research Project Grant award mechanism